SLXNW

Warrants to purchase shares of Silexion Therapeutics Corp, a biopharmaceutical company developing RNA interference therapeutics for fibrotic diseases. Each warrant entitles the holder to buy common stock at a predetermined price within a specified timeframe. These warrants trade separately from the underlying common shares.